REMICADE® is a proven treatment that can provide relief of both the spinal and additional symptoms of AS. If you've been diagnosed with ankylosing spondylitis (AS), REMICADE® may be able to help. In clinical trials, for many patients, REMICADE® was shown to improve the symptoms of AS, including:
- Spinal pain
- Joint pain
- Heel pain (enthesitis)
- Morning stiffness
- Range of motion
Of course, individual results may vary. As with any medication, it's important to keep your doctor informed about the impact of REMICADE® on your symptoms.
More about REMICADE®
REMICADE® is given as an IV infusion over 2 hours by a healthcare professional. This is followed by 2 more 2-hour infusions at 2 and 6 weeks after the first infusion. After the first 3 infusions, you'll need REMICADE® only once every 6 weeks. That adds up to just 9 times a year after the first 3 starter doses. From its approval in August 1998 through August 2010, REMICADE® has been used to treat more than 1.3 million people worldwide who have AS or other inflammatory conditions, such as rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, Crohn's disease, or ulcerative colitis.
REMICADE® can lower your ability to fight infections. Serious and sometimes fatal events can occur. There have been reports of serious infections including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses that have spread throughout the body. Lymphoma, including a fatal kind called hepatosplenic T-cell lymphoma, and other cancers have been reported in children and adults taking REMICADE®. Some people with heart failure should not take REMICADE®. Other serious side effects reported include skin cancer, hepatitis B, liver injury, blood problems, allergic reactions, nervous system problems, or lupus-like syndrome. To learn more about these and other risks, please read the Important Safety Information and the Medication Guide , and talk with your doctor.
Ask your rheumatologist if REMICADE® is right for you.